[1] KIM K,JUNG S,KIM M,et al.Global trends in the proportion of macrolide-resistant mycoplasma pneumoniae infections:A systematic review and meta-analysis[J].JAMA Netw Open,2022,5(7):e2220949. [2] WANG Y S,ZHOU Y L,BAI G N,et al.Expert consensus on the diagnosis and treatment of macrolide-resistant Mycoplasma pneumoniae pneumonia in children[J].World J Pediatr,2024,20(9):901-914. [3] ZHUO L Y,HAO J W,SONG Z J,et al.Predicting the severity of mycoplasma pneumoniae pneumonia in pediatric and adult patients:A multicenter study[J].Sci Rep,2024,14(1):22978. [4] ZHANG X,SUN R,JIA W,et al.A new dynamic nomogram for predicting the risk of severe Mycoplasma pneumoniae pneumonia in children[J].Sci Rep,2024,14(1):8260. [5] LI L,GUO R,ZOU Y,et al.Construction and validation of a nomogram model to predict the severity of Mycoplasma pneumoniae Pneumonia in Children[J].J Inflamm Res,2024(17):1183-1191. [6] RILEY R D,ENSOR J,SNELL K I E,et al.Calculating the sample size required for developing a clinical prediction model[J].BMJ,2020(368):m441. [7] YUAN X,XU Q,DU F,et al.Development and validation of a model to predict cognitive impairment in traumatic brain injury patients:A prospective observational study[J].EClinicalMedicine,2025(80):103023. [8] 倪鑫. 儿童社区获得性肺炎诊疗规范(2019年版)[J].全科医学临床与教育,2019,17(9):771-777. [9] YANG T I,CHANG T H,LU C Y,et al.Mycoplasma pneumoniae in pediatric patients:Do macrolide-resistance and/or delayed treatment matter?[J].J Microbiol Immunol Infect,2019,52(2):329-335. [10] 谢正德,邓继岿,任丽丽,等.儿童呼吸道感染病原体核酸检测专家共识[J].中华实用儿科临床杂志,2022,37(5):321-332. [11] 中华人民共和国国家卫生健康委员会.儿童肺炎支原体肺炎诊疗指南(2023年版)[J].国际流行病学传染病学杂志,2023,50(2):79-85. [12] 奚丽婧,郭昭艳,杨雪珂,等.LASSO及其拓展方法在回归分析变量筛选中的应用[J].中华预防医学杂志,2023,57(1):107-111. [13] GAO L,SHEN W,WU F,et al.Real-time predictive model of extrauterine growth retardation in preterm infants with gestational age less than 32 weeks[J].Sci Rep,2024,14(1):12884. [14] LI C,ZHANG H,YIN W,et al.Development and validation of a nomogram-based prognostic model to predict coronary artery lesions in Kawasaki disease from6847 children in China[J].Comput Methods Programs Biomed,2025(260):108588. [15] LUO Y,GUO Y,WANG Y,et al.Development and validation of a simple-to-use nomogram for predicting severe scrub typhus in children[J].PLoS Negl Trop Dis,2025,19(5):e0013090. [16] HU J,YE Y,CHEN X,et al.Insight into the pathogenic mechanism of mycoplasma pneumoniae[J].Curr Microbiol,2022,80(1):14. [17] 陈梦雪,李京阳,杨芬,等.儿童大环内酯类耐药重症肺炎支原体肺炎的临床特征及危险因素分析[J].临床儿科杂志,2024,42(3):187-192. [18] WANG L P,HU Z H,JIANG J S,et al.Serum inflammatory markers in children with Mycoplasma pneumoniae pneumonia and their predictive value for mycoplasma severity[J].World J Clin Cases,2024,12(22):4940-4946. [19] LIU F,CHEN L,WANG M Y,et al.Exploring high-risk factors for the prediction of severe mycoplasma pneumonia in children[J].Transl Pediatr,2024,13(11):2003-2011. [20] WANG S,JIANG Z,LI X,et al.Diagnostic value of serum LDH in children with refractory Mycoplasma pneumoniae pneumoniae:A systematic review and meta-analysis[J].Front Pediatr,2023(11):1094118. [21] REN Y,ZHAO S,CHEN D,et al.Predictive value of lactate dehydrogenase for Mycoplasma pneumoniae necrotizing pneumonia in children based on decision curve analysis and dose-response analysis[J].Sci Rep,2024,14(1):9803. [22] 李洪娜,郭艳霞,谢金霞,等.肺炎支原体肺炎患儿血清ALT、AST水平变化及其对预后的预测价值[J].山东医药,2023,63(23):55-57. [23] ZHANG X,SUN R,JIA W,et al.Clinical characteristics of lung consolidation with mycoplasma pneumoniae pneumonia and risk factors for mycoplasma pneumoniae necrotizing pneumonia in children[J].Infect Dis Ther,2024,13(2):329-343. [24] 胡楠,屈福祥,程旺,等.儿童重症支原体肺炎风险因素阈值与预测价值[J].西南医科大学学报,2024,47(3):226-230. [25] TANAKA H.Correlation between radiological and pathological findings in patients with mycoplasma pneumoniae pneumonia[J].Front Microbiol,2016(7):695. [26] CHU C,WANG L,WU Y,et al.Multidimensional analysis using low-dose computed tomography to evaluate the severity of Mycoplasma pneumoniae pneumonia in children[J].Quant Imaging Med Surg,2023,13(3):1874-1886. [27] WEI J,WU S,JIN X,et al.Association of Mycoplasma pneumoniae coinfection with adenovirus pneumonia severity in children[J].Allergol Immunopathol(Madr),2022,50(1):31-36. [28] 孔祥玉,黄元元.儿童肺炎支原体肺炎合并EB病毒感染的临床表现及危险因素分析[J].广州医药,2023,54(7):73-77. [29] 刘满姣,钱星星,皮胜男,等.腺病毒合并肺炎支原体感染患儿临床特征分析[J].国际医药卫生导报,2024,30(24):4115-4119. [30] YU A,RAN L,SUN X,et al.Significance of respiratory virus coinfection in children with Mycoplasma pneumoniae pneumonia[J].BMC Pulm Med,2024,24(1):585. |